Anebulo Pharmaceuticals (ANEB) Net Equity Issued and Repurchased (2022)
Anebulo Pharmaceuticals (ANEB) posted quarterly Net Equity Issued and Repurchased of $6.6 million for Q3 2022.
Anebulo Pharmaceuticals (ANEB) Net Equity Issued and Repurchased (2022) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $6.6 million the latest figure, recorded in Q3 2022.
- In Q3 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $6.6 million; the TTM figure through Jun 2023 stood at $6.6 million (changed N/A YoY), while the FY2025 annual figure was $15.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased held at $6.6 million in Q3 2022 per ANEB's latest filing.
- Across five years, Net Equity Issued and Repurchased topped out at $6.6 million in Q3 2022 and bottomed at $6.6 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 6.65 Mn |
| Sep 30, 2022 | 6.65 Mn |